FDA advisory panel reviews pain-killing drugs
March 7, 2005 – That question was posed by the headline of a CBS online report that took a close look at the FDA advisory panel that voted to allow the pain-killing drugs Vioxx, Celebrex and Bextra to stay on the market... Read More >


